GRDX
Entero Therapeutics, Inc.
NASDAQ: GRDX · HEALTHCARE · BIOTECHNOLOGY
$2.51
+17.29% today
Updated 2026-04-30
Market cap
$7.56M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-11.66
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
Entero Therapeutics, Inc. (GRDX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | $429935.00 | $733599.00 | $734500.00 | $753998.00 | $798446.00 | $976982.00 | $571145.00 | $537400.00 | $106207.00 | $29274.00 | $48946.00 |
| Gross profit | — | $-429935.00 | $-733599.00 | $-734500.00 | $-753998.00 | $-798446.00 | $-976982.00 | $-571145.00 | $-537400.00 | $-106207.00 | $-29274.00 | $-48946.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $432.00 | $1050.00 | $1398.00 | $2496.00 | $2395.00 | $5771.00 | $8680.00 | $19.14M | $38.32M | $691257.00 | $5.03M | $903.00 |
| SG&A | $536.00 | $1865.00 | $3330.00 | $4129.00 | $7685.00 | $7450.00 | $6063.00 | $7.29M | $18.38M | $11.99M | $10.74M | $14.72M |
| Operating income | $-969.00 | $-2.33M | $-4.73M | $-6.63M | $-10.08M | $-12.79M | $-14.37M | $-26.43M | $-59.06M | $-12.68M | $-15.77M | $-15.62M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-957.00 | $-1.87M | $-3.61M | $-7.92M | $-9.47M | $-12.63M | $-13.77M | $-26.26M | $-57.99M | $-14.58M | $-15.74M | $-15.57M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-968.00 | $-2.30M | $-4.34M | $-8.65M | $-10.22M | $-13.43M | $-14.74M | $-26.83M | $-58.53M | $-14.61M | $-15.77M | $-15.62M |
| Interest expense | — | $68149.00 | $1.59M | $5.94M | $875199.00 | $101846.00 | $433939.00 | $5.84M | $11235.00 | $15879.00 | $22463.00 | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1014.00 | $-2.37M | $-5.93M | $-14.59M | $-11.10M | $-13.53M | $-15.18M | $-32.67M | $-58.54M | $-14.63M | $-15.79M | $-18.06M |
| Net income growth (YoY) | — | -233149.3% | -150.7% | -146.1% | +24.0% | -22.0% | -12.1% | -115.3% | -79.2% | +75.0% | -8.0% | -14.3% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — |